Loading…
Sectoral / Thematic · quant Mutual Fund · AMFI code 151853quant Healthcare Fund
Disclosed for 1 months, Sep 2026 to Sep 2026.
Portfolio value
₹425 Cr
Sep 2026
- Stocks held
- 16
- Top 10 weight
- 84.9%
- of the portfolio in its ten largest
- Cash & debt
- 0.6%
- cash, money market and debt
- Moves this month
- —
- no earlier month
quant Healthcare Fund is an active equity fund in the Sectoral / Thematic category from quant Mutual Fund. In September 2026 it disclosed 16 stocks worth ₹425 Cr. Its largest positions were GlaxoSmithKline Pharmaceuticals Limited (9.7%), Divi's Laboratories Limited (9.6%), Aurobindo Pharma Limited (9.6%); the ten largest together made up 84.9% of the portfolio, and Pharmaceuticals & Biotechnology was the biggest sector at 81.7% of its equity. Cash and debt stood at 0.6%.
Against 226 other Sectoral / Thematic funds
Concentration
100%
Top-10 weight is higher than 100% of peers
Breadth
2%
Holds more stocks than 2% of peers
Cash
8%
Holds more cash than 8% of peers
Holdings in September 2026
Download CSVEvery line the fund disclosed, with the change against the previous month. Click a column to sort; click a company to see every fund that owns it.
- Weight
- 9.69%
- Δ weight
- —
- Value
- ₹41.1 Cr
- Δ value
- —
- Status
- Weight
- 9.63%
- Δ weight
- —
- Value
- ₹40.9 Cr
- Δ value
- —
- Status
- Weight
- 9.61%
- Δ weight
- —
- Value
- ₹40.8 Cr
- Δ value
- —
- Status
- Weight
- 9.39%
- Δ weight
- —
- Value
- ₹39.8 Cr
- Δ value
- —
- Status
- Weight
- 9.34%
- Δ weight
- —
- Value
- ₹39.6 Cr
- Δ value
- —
- Status
- Weight
- 9.04%
- Δ weight
- —
- Value
- ₹38.4 Cr
- Δ value
- —
- Status
- Weight
- 8.62%
- Δ weight
- —
- Value
- ₹36.6 Cr
- Δ value
- —
- Status
- Weight
- 7.37%
- Δ weight
- —
- Value
- ₹31.3 Cr
- Δ value
- —
- Status
- Weight
- 6.21%
- Δ weight
- —
- Value
- ₹26.4 Cr
- Δ value
- —
- Status
- Weight
- 5.98%
- Δ weight
- —
- Value
- ₹25.4 Cr
- Δ value
- —
- Status
- Weight
- 4.90%
- Δ weight
- —
- Value
- ₹20.8 Cr
- Δ value
- —
- Status
- Weight
- 3.45%
- Δ weight
- —
- Value
- ₹14.6 Cr
- Δ value
- —
- Status
- Weight
- 3.01%
- Δ weight
- —
- Value
- ₹12.8 Cr
- Δ value
- —
- Status
- Weight
- 2.33%
- Δ weight
- —
- Value
- ₹9.9 Cr
- Δ value
- —
- Status
- 91 Days Tbill (MDDebt
- Weight
- 0.71%
- Δ weight
- —
- Value
- ₹3 Cr
- Δ value
- —
- Status
- 91 Days Tbill (MDDebt
- Weight
- 0.70%
- Δ weight
- —
- Value
- ₹3 Cr
- Δ value
- —
- Status
- 91 Days Tbill (MDDebt
- Weight
- 0.70%
- Δ weight
- —
- Value
- ₹3 Cr
- Δ value
- —
- Status
- 91 Days Treasury Bill 19-Nov-2026Debt
- Weight
- 0.70%
- Δ weight
- —
- Value
- ₹3 Cr
- Δ value
- —
- Status
- 91 Days Treasury Bill 27-Nov-2026Debt
- Weight
- 0.70%
- Δ weight
- —
- Value
- ₹3 Cr
- Δ value
- —
- Status
- 91 Days Treasury Bill 03-Dec-2026Debt
- Weight
- 0.70%
- Δ weight
- —
- Value
- ₹3 Cr
- Δ value
- —
- Status
- 91 Days Tbill (MDDebt
- Weight
- 0.70%
- Δ weight
- —
- Value
- ₹3 Cr
- Δ value
- —
- Status
- 91 Days Treasury Bill 17-Dec-2026Debt
- Weight
- 0.70%
- Δ weight
- —
- Value
- ₹3 Cr
- Δ value
- —
- Status
- 91 Day Treasury BillsDebt
- Weight
- 0.70%
- Δ weight
- —
- Value
- ₹3 Cr
- Δ value
- —
- Status
- Weight
- 0.59%
- Δ weight
- —
- Value
- ₹2.5 Cr
- Δ value
- —
- Status
- Weight
- 0.26%
- Δ weight
- —
- Value
- ₹1.1 Cr
- Δ value
- —
- Status
- Cash, TREPS & receivables
- Weight
- −5.73%
- Δ weight
- —
- Value
- −₹24.3 Cr
- Δ value
- —
- Status
What changed
This is the earliest month on record for the fund.
Sectors
Which sectors the fund is moving towards and away from, and where its money sits now. Shares are of the fund’s classified equity holdings, so they add up to 100%.
Where the weight moved
No earlier month with a sector split to compare against.
Allocation in Sep 2026
- Pharmaceuticals & Biotechnology (11)81.7%
- Pharmaceuticals (1)9.1%
- Food Products (1)4.9%
- Personal Products (1)3.5%
- Consumer Durables (1)0.6%
Cash and debt
The share of the portfolio not in shares: cash and net receivables, money-market instruments and bonds, as disclosed each month. Cash can dip below zero when payables, often on derivative positions, exceed it. A change here describes what the fund did; it is not a signal.
Cash & debt, Sep 2026
0.6%
- Cash alone
- −5.7%
- cash and net receivables
- A year earlier
- —
- no disclosure
- Last 12 months
- —
- lowest to highest · record 0.6% in Sep 2026
Not enough months to draw.
History
Disclosed portfolio value by month, with the stocks the fund entered and exited against its previous disclosure. Every month is a link to that portfolio.
Not enough months to draw.
All 1 months
| Month | Portfolio value | Stocks | Entered | Exited | Cash | Cash & debt | Turnover |
|---|---|---|---|---|---|---|---|
| Sep 2026 | ₹425 Cr | 16 | −5.7% | 0.6% | 5% |